Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

8
Number of overlapping holdings
16.0%
% of CANC's 50 holdings also in PBE
28.6%
% of PBE's 28 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in CANC |
Weight in PBE |
Overlap | |
---|---|---|---|---|
EXELIXIS INC | 4.1% | 3.0% | 3.0% | |
AMGEN INC | 3.0% | 5.7% | 3.0% | |
BLUEPRINT MEDICINES CORP. | 2.7% | 2.6% | 2.6% | |
GILEAD SCIENCES INC | 1.9% | 6.7% | 1.9% | |
REGENERON PHARMACEUTICALS | 1.1% | 4.9% | 1.1% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to PBE
ELI LILLY & CO | 5.4% | |
ROCHE HOLDINGS LTD-SPONS ADR | 5.2% | |
REVOLUTION MEDICINES, INC. | 5.1% | |
BRISTOL-MYERS SQUIBB CO | 4.5% | |
ASTRAZENECA PLC | 4.5% | |
NOVARTIS AG | 4.1% | |
GENMAB A/S SPONSORED ADR | 3.7% | |
BRIDGEBIO PHARMA, INC. | 3.6% | |
NUVALENT, INC. CLASS A | 3.6% | |
CHUGAI PHARMACEUTICAL CO LTD | 3.1% |
CANC Underweight Relative to PBE
BIOGEN IDEC INC | -4.9% | |
GILEAD SCIENCES INC | -4.8% | |
UNITED THERAPEUTICS CORP | -4.5% | |
NATERA INC | -4.4% | |
INCYTE CORP | -4.2% | |
REGENERON PHARMACEUTICALS | -3.8% | |
HALOZYME THERAPEUTICS INC | -3.6% | |
AXSOME THERAPEUTICS, INC. | -3.6% | |
ROYALTY PHARMA PLC CLASS A | -3.5% | |
TG THERAPEUTICS INC | -3.1% |